EUGENEX Biotechnologies

EUGENEX Biotechnologies is a Swiss-based biotechnology company specializing in the development of high-performance mammalian cell lines for the production of recombinant proteins and monoclonal antibodies. The company's core technology is the proprietary CHO-E expression platform, which is designed to achieve high yields and stable production for biopharmaceutical manufacturing. EUGENEX provides services ranging from vector construction and transfection to the delivery of stable, high-producing clones ready for clinical and commercial production. Their business model includes both fee-for-service cell line development and technology licensing to pharmaceutical and biotech partners globally. The company is led by industry veterans with significant expertise in bioprocessing and regulatory requirements for biologics.